{"data":[{"accessionNo":"0001104659-25-092675","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001455365","issuerName":"Cognition Therapeutics, Inc.","ticker":"CGTX","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-19","reportingPerson":"AARON G.L. FLETCHER","reportingCik":"0001789490","personType":"IN","sharesOwned":6059555,"percentOfClass":6.9,"filedAt":"2025-09-23","canonicalUrl":"https://xoomar.com/markets/stocks/cgtx"},{"accessionNo":"0001104659-25-092675","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001455365","issuerName":"Cognition Therapeutics, Inc.","ticker":"CGTX","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-19","reportingPerson":"BIOS ADVISORS GP, LLC","reportingCik":"0001813844","personType":"PN","sharesOwned":6032328,"percentOfClass":6.8,"filedAt":"2025-09-23","canonicalUrl":"https://xoomar.com/markets/stocks/cgtx"},{"accessionNo":"0001104659-25-092675","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001455365","issuerName":"Cognition Therapeutics, Inc.","ticker":"CGTX","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-19","reportingPerson":"BIOS CAPITAL MANAGEMENT, LP","reportingCik":"0001813845","personType":"PN","sharesOwned":6032328,"percentOfClass":6.8,"filedAt":"2025-09-23","canonicalUrl":"https://xoomar.com/markets/stocks/cgtx"},{"accessionNo":"0001104659-25-092675","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001455365","issuerName":"Cognition Therapeutics, Inc.","ticker":"CGTX","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-19","reportingPerson":"CAVU MANAGEMENT, LP","reportingCik":"0001813270","personType":"PN","sharesOwned":5532233,"percentOfClass":6.3,"filedAt":"2025-09-23","canonicalUrl":"https://xoomar.com/markets/stocks/cgtx"},{"accessionNo":"0001104659-25-092675","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001455365","issuerName":"Cognition Therapeutics, Inc.","ticker":"CGTX","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-19","reportingPerson":"LESLIE W. KREIS","reportingCik":"0001813316","personType":"IN","sharesOwned":5532233,"percentOfClass":6.3,"filedAt":"2025-09-23","canonicalUrl":"https://xoomar.com/markets/stocks/cgtx"},{"accessionNo":"0001104659-25-092675","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001455365","issuerName":"Cognition Therapeutics, Inc.","ticker":"CGTX","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-19","reportingPerson":"CAVU ADVISORS, LLC","reportingCik":"0001813310","personType":"PN","sharesOwned":5532233,"percentOfClass":6.3,"filedAt":"2025-09-23","canonicalUrl":"https://xoomar.com/markets/stocks/cgtx"},{"accessionNo":"0001104659-25-092675","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001455365","issuerName":"Cognition Therapeutics, Inc.","ticker":"CGTX","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-19","reportingPerson":"BIOS EQUITY PARTNERS III, LP","reportingCik":"0001831976","personType":"PN","sharesOwned":2658387,"percentOfClass":3,"filedAt":"2025-09-23","canonicalUrl":"https://xoomar.com/markets/stocks/cgtx"},{"accessionNo":"0001104659-25-092675","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001455365","issuerName":"Cognition Therapeutics, Inc.","ticker":"CGTX","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-19","reportingPerson":"BIOS FUND III QP, LP","reportingCik":"0001791916","personType":"PN","sharesOwned":2021906,"percentOfClass":2.3,"filedAt":"2025-09-23","canonicalUrl":"https://xoomar.com/markets/stocks/cgtx"},{"accessionNo":"0001104659-25-092675","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001455365","issuerName":"Cognition Therapeutics, Inc.","ticker":"CGTX","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-19","reportingPerson":"BIOS MEMORY SPV I, LP","reportingCik":"0001643749","personType":"PN","sharesOwned":1424014,"percentOfClass":1.6,"filedAt":"2025-09-23","canonicalUrl":"https://xoomar.com/markets/stocks/cgtx"},{"accessionNo":"0001104659-25-092675","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001455365","issuerName":"Cognition Therapeutics, Inc.","ticker":"CGTX","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-19","reportingPerson":"BIOS EQUITY PARTNERS, LP","reportingCik":"0001813314","personType":"PN","sharesOwned":1081531,"percentOfClass":1.2,"filedAt":"2025-09-23","canonicalUrl":"https://xoomar.com/markets/stocks/cgtx"},{"accessionNo":"0001104659-25-092675","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001455365","issuerName":"Cognition Therapeutics, Inc.","ticker":"CGTX","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-19","reportingPerson":"BIOS CLINICAL OPPORTUNITY FUND, LP","reportingCik":"0001988639","personType":"PN","sharesOwned":500095,"percentOfClass":0.6,"filedAt":"2025-09-23","canonicalUrl":"https://xoomar.com/markets/stocks/cgtx"},{"accessionNo":"0001104659-25-092675","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001455365","issuerName":"Cognition Therapeutics, Inc.","ticker":"CGTX","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-19","reportingPerson":"BIOS EQUITY COF, LP","reportingCik":"0002000747","personType":"PN","sharesOwned":500095,"percentOfClass":0.6,"filedAt":"2025-09-23","canonicalUrl":"https://xoomar.com/markets/stocks/cgtx"},{"accessionNo":"0001104659-25-092675","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001455365","issuerName":"Cognition Therapeutics, Inc.","ticker":"CGTX","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-19","reportingPerson":"BIOS FUND I, LP","reportingCik":"0001697316","personType":"PN","sharesOwned":418926,"percentOfClass":0.5,"filedAt":"2025-09-23","canonicalUrl":"https://xoomar.com/markets/stocks/cgtx"},{"accessionNo":"0001104659-25-092675","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001455365","issuerName":"Cognition Therapeutics, Inc.","ticker":"CGTX","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-19","reportingPerson":"BIOS MEMORY SPV II, LP","reportingCik":"0001666485","personType":"PN","sharesOwned":385248,"percentOfClass":0.4,"filedAt":"2025-09-23","canonicalUrl":"https://xoomar.com/markets/stocks/cgtx"},{"accessionNo":"0001104659-25-092675","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001455365","issuerName":"Cognition Therapeutics, Inc.","ticker":"CGTX","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-19","reportingPerson":"BIOS FUND III NT, LP","reportingCik":"0001791910","personType":"PN","sharesOwned":326733,"percentOfClass":0.4,"filedAt":"2025-09-23","canonicalUrl":"https://xoomar.com/markets/stocks/cgtx"},{"accessionNo":"0001104659-25-092675","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001455365","issuerName":"Cognition Therapeutics, Inc.","ticker":"CGTX","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-19","reportingPerson":"BIOS EQUITY PARTNERS II, LP","reportingCik":"0001813313","personType":"PN","sharesOwned":368301,"percentOfClass":0.4,"filedAt":"2025-09-23","canonicalUrl":"https://xoomar.com/markets/stocks/cgtx"},{"accessionNo":"0001104659-25-092675","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001455365","issuerName":"Cognition Therapeutics, Inc.","ticker":"CGTX","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-19","reportingPerson":"BIOS FUND III, LP","reportingCik":"0001791917","personType":"PN","sharesOwned":309748,"percentOfClass":0.4,"filedAt":"2025-09-23","canonicalUrl":"https://xoomar.com/markets/stocks/cgtx"},{"accessionNo":"0001104659-25-092675","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001455365","issuerName":"Cognition Therapeutics, Inc.","ticker":"CGTX","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-19","reportingPerson":"BIOS FUND I QP, LP","reportingCik":"0001700297","personType":"PN","sharesOwned":245029,"percentOfClass":0.3,"filedAt":"2025-09-23","canonicalUrl":"https://xoomar.com/markets/stocks/cgtx"},{"accessionNo":"0001104659-25-092675","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001455365","issuerName":"Cognition Therapeutics, Inc.","ticker":"CGTX","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-19","reportingPerson":"BIOS FUND II QP, LP","reportingCik":"0001716869","personType":"PN","sharesOwned":255765,"percentOfClass":0.3,"filedAt":"2025-09-23","canonicalUrl":"https://xoomar.com/markets/stocks/cgtx"},{"accessionNo":"0001104659-25-092675","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001455365","issuerName":"Cognition Therapeutics, Inc.","ticker":"CGTX","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-19","reportingPerson":"BIOS FUND II, LP","reportingCik":"0001714576","personType":"PN","sharesOwned":78298,"percentOfClass":0.1,"filedAt":"2025-09-23","canonicalUrl":"https://xoomar.com/markets/stocks/cgtx"},{"accessionNo":"0001104659-25-092675","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001455365","issuerName":"Cognition Therapeutics, Inc.","ticker":"CGTX","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-19","reportingPerson":"BP DIRECTORS, LP","reportingCik":"0001813311","personType":"PN","sharesOwned":32328,"percentOfClass":0.04,"filedAt":"2025-09-23","canonicalUrl":"https://xoomar.com/markets/stocks/cgtx"},{"accessionNo":"0001104659-25-092675","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001455365","issuerName":"Cognition Therapeutics, Inc.","ticker":"CGTX","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-19","reportingPerson":"BIOS FUND II NT, LP","reportingCik":"0001728851","personType":"PN","sharesOwned":34238,"percentOfClass":0.04,"filedAt":"2025-09-23","canonicalUrl":"https://xoomar.com/markets/stocks/cgtx"}],"updatedAt":"2026-11-05T15:31:49.888Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/cgtx","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}